Self-Care Practices with Psychedelics - A Qualitative Study of Users' Perspectives.
Carla Mendes Soares, Ângela Leite, Marta Pinto
Journal of Psychoactive Drugs 2023 DOI: 10.1080/02791072.2022.2071134 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 19 |
| Population | Psychedelic users |
| Keywords | Psychedelics Qualitative research Hallucinogens Self-care |
| Citations | 10 |
| Key findings | Psychedelic use may be experienced as part of a self-care process and may improve self-care abilities in naturalistic settings. |
Abstract
This article explores the psychedelic experience from the users' point of view and through the lens of self-care, a concept within the domain of health and well-being. In a time of renewed interest in psychedelic-assisted psychotherapy, we aim to contribute to a better understanding of these substances by exploring their role in different settings. A phenomenological approach was used in this study. We conducted semi-structured interviews with 19 psychedelic users and inquired about the relationship between their experiences and self-care. Analysis of the interview data was based on inductive content analysis. Most participants reported using psychedelics with self-care intentions in ceremonial, recreational, or private settings. Self-perception and existential meaningfulness were identified as the main mechanisms of self-care. Participants also mentioned difficult experiences and adversities that impair self-care. The results suggest that for some people, the use of psychedelics may be experienced as part of a self-care process and may improve self-care abilities in naturalistic settings.
Citations in the library
Cited by 10
- Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Journal of Psychopharmacology March 6, 2023
- Development of a digital intervention for psychedelic preparation (DIPP). Scientific Reports February 19, 2024
- Exploring the subjective experience of rave party participants in Israel who consume psychedelic drugs: a qualitative inquiry. Harm Reduction Journal December 6, 2023
- Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories. Progress in Neuro-Psychopharmacology and Biological Psychiatry April 2, 2025
- Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers. Psychopharmacology March 26, 2025
and 5 more in the library
Cites 30
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 25 more in the library